Science Explorer Interactive view Map
Company · Lexington · United States

Cyteir Therapeutics (United States)

cyteir.comROR OpenAlex
Research works
13
▲ 1234% vs 2013–17
Citations
51
3.8 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
14%
world 28%

Not ranked overall: Cyteir Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Cyteir Therapeutics (United States) publish most on?

By volume in 2022–2025: Cancer, Hypoxia, and Metabolism, Metabolomics and Mass Spectrometry Studies, RNA Research and Splicing and Advanced Breast Cancer Therapies.

Cancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksMetabolomics and Mass Spectrometry Studies: 0 fractional worksRNA Research and Splicing: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional works14-3-3 protein interactions: 0 fractional works
Cancer ResearchMolecular BiologyPulmonary and Respiratory MedicineOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  2. 2 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
  3. 3 RNA Research and Splicing Molecular Biology 0 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  5. 5 Peptidase Inhibition and Analysis Oncology 0 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 14-3-3 protein interactions Molecular Biology 0 works
  8. 8 Cancer Treatment and Pharmacology Oncology 0 works
  9. 9 PARP inhibition in cancer therapy Oncology 0 works
  10. 10 DNA Repair Mechanisms Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.8%not open86.2%

World: 28% of research is openly available.

with international co-authors5.5%domestic only94.5%

World: 19% is written across borders.

How has Cyteir Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 1234% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.